- Report
- November 2023
- 144 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- January 2022
- 276 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- July 2018
- 765 Pages
Global
From €21109EUR$22,000USD£18,253GBP
- Report
- November 2021
- 844 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- May 2020
- 151 Pages
Global
From €5152EUR$5,370USD£4,455GBP
- Report
- April 2023
- 147 Pages
Global
From €5756EUR$5,999USD£4,977GBP
Interferon beta is a type of drug used to treat diseases of the central nervous system (CNS). It is a type of cytokine, a protein that helps regulate the immune system. Interferon beta is used to treat multiple sclerosis (MS), a chronic autoimmune disorder of the CNS. It is also used to treat other neurological conditions such as optic neuritis, transverse myelitis, and neuromyelitis optica. Interferon beta works by reducing inflammation and slowing the progression of MS.
Interferon beta is available in both injectable and oral forms. It is typically prescribed in combination with other medications to treat MS. Common side effects of interferon beta include flu-like symptoms, fatigue, and injection site reactions.
Companies in the interferon beta market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more
